Navigation Links
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
Date:6/29/2011

BLUE BELL, Pa., June 29, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its therapeutic DNA vaccine for prostate cancer showed remarkable immune responses in monkeys, following similarly strong, antigen-specific and sustainable T cell levels in previously reported data from earlier animal studies. The data was presented by Dr. J. Joseph Kim, Ph.D., president & CEO of Inovio, at the BIO International Convention in Washington, DC. The strength of this new large animal data reinforces Inovio's plan to start a Phase I clinical trial for this prostate cancer DNA vaccine (INO-5150) by mid-year 2012.

In this monkey trial, vaccinations with INO-5150, Inovio's SynCon™ therapeutic DNA vaccine for prostate cancer, generated strong and robust T cell immune responses. The level of T cell responses from this INO-5150 study was similar to the level of T cell responses observed from a previously conducted monkey study of VGX-3100, Inovio's Phase II-stage therapeutic vaccine for cervical cancer and dysplasia. In a Phase I study, VGX-3100 generated best-in-class T cell responses, which were persistent through the complete study duration of nine months.

In a prior study in mice, INO-5150 immunization induced potent antibody and T cell responses, providing initial evidence that its concept for a therapeutic DNA vaccine comprising a broader collection of antigens, administered with Inovio's electroporation-based delivery technology, would improve the breadth and effectiveness of a prostate cancer immunotherapy. Furthermore, the SynCon™ DNA vaccine evaluated in this study was generated by the creation of PSA and PSMA synthetic consensus immunogens based on human and macaque sequences, which enabled the amino acid sequences of th
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference
2. Inovio Pharmaceuticals Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease
3. Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
4. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
6. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
7. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
8. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
9. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
10. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
11. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Arizona (PRWEB) January 15, 2014 2013 ... for Scottsdale’s Brain State Technologies®. They saw continued independent ... Medical Center who were awarded a $1 million grant ... published in “Brain and Behavior” a peer reviewed journal, ...
(Date:1/14/2014)... 14, 2014 Carahsoft and CDS Federal ... 23, 2014 at 2pm EST (11am PST), “Natural Language ... focuses on how technology can turn raw, heterogeneous data ... government agencies. The online webinar will last approximately one ...
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... What do Saturn and flowers have in common? , ... recognizable in the natural world. Now, at an extremely ... of Massachusetts have created a unique set of conditions ... consistently assemble themselves into these and other complex shapes. ...
... (Nasdaq: FOLD ) announced today that Stephen ... resigned from the Company,s Board of Directors effective February ... of Amicus, board since 2004. About Amicus Therapeutics ... novel, oral therapeutics known as pharmacological chaperones for the ...
... Directors wishes to confirm to Stockholders that at its meeting ... 15 with effect from February 17, 2009. This initiative ... interests of keeping stockholders and other stakeholders informed the Board ... release the company from its United States Securities and Exchange ...
Cached Biology Technology:Sophisticated nano-structures assembled with magnets 2Sophisticated nano-structures assembled with magnets 3EESTECH Inc - Release From SEC Filing 2EESTECH Inc - Release From SEC Filing 3EESTECH Inc - Release From SEC Filing 4
(Date:4/24/2014)... A new study from investigators with the Autism ... on identifying genes associated with risk for autism, has ... (CNV) genetic testing offers an important tool in individualized ... by Autism Speaks, the world,s leading autism science and ... 50 research centers in 11 countries. The report, published ...
(Date:4/24/2014)... bacteria attack plants, they often inject harmful proteins ... suppress natural defenses. However, in some plants, bacteria ... a potential host. Now, researchers at the University ... that allows the bacteriaknown mostly for attacking tomatoesto ... natural anti-infective treatments that work with food-producing plants ...
(Date:4/24/2014)... shows that cells are more resilient in taking care ... missing critical components, cells can adapt and make copies ... a study published in this week,s Cell Reports ... showed that cells can grow normally without a crucial ... information is stored in DNA, which has to be ...
Breaking Biology News(10 mins):Autism Genome Project delivers genetic discovery 2Autism Genome Project delivers genetic discovery 3Plants send out signals attracting harmful bacteria, MU study finds 2Cell resiliency surprises scientists 2
... to improve nutrition, indoor air pollution, immunization coverage and ... significantly reduce child mortality from pneumonia, according to a ... Public Health. Researchers found that these strategies combined could ... reduce pneumonia deaths by more than 90 percent. Pneumonia ...
... found at health food stores could be the key to ... cause diarrhea, tooth decay and, in some severe cases, death. ... of proteins in both bacterial cells and human cells called ... shows that interrupting the way selenoproteins are made can halt ...
... from the perspective of cell biology, Nietzsche may have been ... make us stronger. In a review article published in the ... ( http://www.fasebj.org ), scientists from the Mayo Clinic explain how ... shut down old, diseased, or otherwise unwanted cells (called "apoptosis") ...
Cached Biology News:Cost-effective measures could stop child pneumonia deaths 2Newly discovered reactions from an old drug may lead to new antibiotics 2Scientists explain how 'death receptors' designed to kill our cells may make them stronger 2
Mouse monoclonal antibody to DCAMKL2 - doublecortin and CaM kinase-like 2...
...
...
... an imaging based plate reader for ... throughput screening which can utilize both ... light sources and cameras in the ... in photon detection technology. It ...
Biology Products: